|
|
|
Home > Business > Corporate Headline > Quick Company Info
Morepen expects sales to rise by Rs 100 cr
February 11, 2003 14:28 IST
Morepen Laboratories expects revenues and net to rise by $20 million (Rs 1000 million) and $10-12 million (Rs 500-600 million) respectively, enhanced by a 180-day marketing exclusivity granted to Geneva Pharmaceuticals Inc for Loratadine in the U S. Morepen is the sole supplier for bulk Loratadine to Geneva Pharma, an arm of Novartis AG. Geneva Pharma already launched its generic version of Claritin in the US market. BSE Code: 500288
|
|
| Article Tools | | |
| Related Stories | | |
| People Who Read This Also Read | | |
|